Correction: Lung cancer stem cells and their aggressive progeny, controlled by EGFR/MIG6 inverse expression, dictate a novel NSCLC treatment approach

Oncotarget. 2021 Aug 17;12(17):1734-1735. doi: 10.18632/oncotarget.28050.

Authors

Zhiguang Xiao^{1

2}, Bianca Sperl¹, Silvia Gärtner¹, Tatiana Nedelko³, Elvira Stacher-Priehse⁴, Axel Ullrich¹, Pjotr G Knyazev^{1

5}

Affiliations

¹ Department of Molecular Biology, Max-Planck Institute of Biochemistry, Martinsried, Munich, 82152, Germany.
² Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA.
³ Department of Medicine III, Klinikum rechts der Isar, TUM, Munich, 81675, Germany.
⁴ Asclepius Institute of Pathology, Gauting, 82131, Germany.
⁵ Current address: DoNatur GmbH, Martinsried, Munich, 82152, Germany.

Abstract

[This corrects the article DOI: 10.18632/oncotarget.26817.].

Copyright: © 2021 Xiao et al.

Publication types

Published Erratum